Obstructive sleep apnoea-hypopnoea (OSAH) syndrome constitutes a major health care problem. Surgical modalities for the treatment of OSAH are regaining momentum in view of the increasing prevalence of OSAH and the low compliance rates associated with continuous positive airway pressure. There are several investigations to complement clinical examination in accurately determining the level of airway collapse to ensure correct patient selection and a targeted surgical approach. The most commonly employed include drug-induced sleep endoscopy and imaging with the tongue base and epiglottis often revealed as the major sites of airway narrowing during sleep. In the continuing search for the optimal approach to address these areas, transoral robotic surgery (TORS) has been successfully used for tongue base reduction and epiglottoplasty. With sufficient experience, this technique is safe and well tolerated. Meticulous work-up and careful patient selection are crucial. Multiple studies have demonstrated very good short-term results of TORS for OSAH, with significant reduction in both the Apnoea-Hypopnea Index (AHI) and Epworth Sleepiness Score (ESS). With the appropriate infrastructure, proctoring, and access to robotic surgical technology, it is possible for these results to be reproduced more widely. Further prospective long-term clinical evaluation will ultimately determine the exact role of TORS in the treatment of OSAH.

Keywords:
Obstructive sleep apnoea, Hypopnoea, Palate, Tongue base, Epiglottis, Hypopharynx, Transoral route, Robotic surgery, Safety, Evidence
1.
Georgalas C, et al: Assessment of obstruction level and selection of patients for obstructive sleep apnoea surgery: an evidence-based approach. J Laryngol Otol 2010; 124: 1–9.
2.
American Academy of Sleep Medicine: Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667–689.
3.
US Preventive Services Task Force: Screening for obstructive sleep apnea in adults: US Preventive Services Task Force recommendation statement. JAMA 2017; 317: 407–414.
4.
Sanchez-de-la-Torre M, Campos-Rodriguez F, Barbe F: Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 2013; 1: 61–72.
5.
Zhou J, et al: A review of neurocognitive function and obstructive sleep apnea with or without daytime sleepiness. Sleep Med 2016; 23: 99–108.
6.
Cho WS, et al: Patient compliance to continuous positive airway pressure (CPAP) therapy for sleep apnoea: a completed audit cycle. Ir J Med Sc 2013; 182:S509–S531.
7.
Kotecha BT, Hall AC: Role of surgery in adult obstructive sleep apnoea. Sleep Med Rev 2014; 18: 405–413.
8.
Garas G, et al: Is transoral robotic surgery a safe and effective multilevel treatment for obstructive sleep apnoea in obese patients following failure of conventional treatment(s)? Ann Med Surg (Lond) 2017; 19: 55–61.
9.
Garas G, Arora A, Tolley N: Robotic surgery of the parathyroid glands; in Grillone G, Jalisi S (eds): Robotic Surgery of the Head and Neck: A Comprehensive Guide. New York, Springer Nature, 2015, pp 133–146.
10.
Garas G, Darzi A, Arora, A, Tolley N: Single-port transaxillary robotic parathyroidectomy; in Gil Z, Amit M, Kupferman ME (eds): Atlas of Head and Neck Robotic Surgery. New York, Springer Nature, 2017, pp 93–106.
11.
Chiffer RC, et al: Volumetric MRI analysis pre- and post-transoral robotic surgery for obstructive sleep apnea. Laryngoscope 2015; 125: 1988–1995.
12.
Moore EJ, Janus J, Kasperbauer J: Transoral robotic surgery of the oropharynx: clinical and anatomic considerations. Clin Anat 2012; 25: 135–141.
13.
Chabolle F, et al: Tongue base reduction with hyoepiglottoplasty: a treatment for severe obstructive sleep apnea. Laryngoscope 1999; 109: 1273–1280.
14.
Farrar J, et al: Radiofrequency ablation for the treatment of obstructive sleep apnea: a meta-analysis. Laryngoscope 2008; 118: 1878–1883.
15.
Friedman M, et al: Evaluation of submucosal minimally invasive lingual excision technique for treatment of obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head Neck Surg 2008; 139: 378–384; discussion 385.
16.
Vicini C, et al: Transoral robotic tongue base resection in obstructive sleep apnoea-hypopnoea syndrome: a preliminary report. ORL J Otorhinolaryngol Relat Spec 2010; 72: 22–27.
17.
Ratneswaran C, Sagoo MK, Steier J: Preface for the 3rd Clinical Update Sleep, 23rd February 2018, Royal College of Physicians, London, UK: year in review. J Thorac Dis 2018; 10(suppl):S1–S23.
18.
Arora A, et al: Outcome of TORS to tongue base and epiglottis in patients with OSA intolerant of conventional treatment. Sleep Breath 2016; 20: 739–747.
19.
Arora A, et al: Determination of biometric measures to evaluate patient suitability for transoral robotic surgery. Head Neck 2015; 37: 1254–1260.
20.
Garas G, et al: Induced bias due to crossover within randomized controlled trials in surgical oncology: a meta-regression analysis of minimally invasive versus open surgery for the treatment of gastrointestinal cancer. Ann Surg Oncol 2017; 25: 221–230.
21.
Lin HS, et al: Transoral robotic surgery for treatment of obstructive sleep apnea-hypopnea syndrome. Laryngoscope 2013; 123: 1811–1816.
22.
Vicini C, et al: Clinical outcomes and complications associated with TORS for OSAHS: a benchmark for evaluating an emerging surgical technology in a targeted application for benign disease. ORL J Otorhinolaryngol Relat Spec 2014; 76: 63–69.
23.
Justin GA, et al: Transoral robotic surgery for obstructive sleep apnea: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2016; 154: 835–846.
24.
Garas G, et al: Evidence-based surgery: barriers, solutions, and the role of evidence synthesis. World J Surg 2012; 36: 1723–1731.
25.
Garas G, et al: Network analysis of surgical innovation: measuring value and the virality of diffusion in robotic surgery. PLoS One 2017; 12:e0183332.
26.
Hoff PT, Glazer TA, Spector ME: Body mass index predicts success in patients undergoing transoral robotic surgery for obstructive sleep apnea. ORL J Otorhinolaryngol Relat Spec 2014; 76: 266–272.
27.
Lin HS, et al: Transoral robotic surgery for treatment of obstructive sleep apnea: factors predicting surgical response. Laryngoscope 2015; 125: 1013–1020.
28.
Eesa M, et al: Swallowing outcome after TORS for sleep apnea: short- and long-term evaluation. Eur Arch Otorhinolaryngol 2015; 272: 1537–1541.
29.
Caples SM, et al: Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep 2010; 33: 1396–1407.
30.
Athanasiou T, et al: Mentoring perception and academic performance: an Academic Health Science Centre survey. Postgrad Med J 2016; 92: 597–602.
31.
Arora A, et al: Comparing transaxillary robotic thyroidectomy with conventional surgery in a UK population: a case control study. Int J Surg 2016; 27: 110–117.
32.
Tolley N, et al: Robotic-assisted parathyroidectomy: a feasibility study. Otolaryngol Head Neck Surg 2011; 144: 859–866.
33.
Tolley N, et al: Long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism. Head Neck 2016; 38:E300–E306.
34.
Malik HT, et al: Savings from reducing low-value general surgical interventions. Br J Surg 2018; 105: 13–25.
35.
Remacle M, et al: Transoral robotic surgery (TORS) with the Medrobotics Flex System: first surgical application on humans. Eur Arch Otorhinolaryngol 2015; 272: 1451–1455.
36.
Mattheis S, et al: Flex robotic system in transoral robotic surgery: the first 40 patients. Head Neck 2017; 39: 471–475.
37.
Tsang RK, Holsinger FC: Transoral endoscopic nasopharyngectomy with a flexible next-generation robotic surgical system. Laryngoscope 2016; 126: 2257–2262.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.